{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:26:36Z","timestamp":1774027596099,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2003,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.fertnstert.2016.08.051","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T08:00:40Z","timestamp":1475913640000},"page":"1807-1814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a\u00a0placebo-controlled, double-blind, randomized trial"],"prefix":"10.1016","volume":"106","author":[{"given":"Tasuku","family":"Harada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-4173","authenticated-orcid":false,"given":"Mikio","family":"Momoeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.08.051_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","article-title":"Primary dysmenorrhea: advances in pathogenesis and management","volume":"108","author":"Dawood","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib2","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.fertnstert.2007.08.051","article-title":"Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial","volume":"90","author":"Harada","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib3","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.fertnstert.2011.02.045","article-title":"Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial","volume":"95","author":"Harada","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1471-0528.1993.tb14309.x","article-title":"Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol","volume":"100","author":"Akerlund","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib5","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib6","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib8","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/humrep\/del230","article-title":"Reproductive performance, pain recurrence and disease relapse after conservative surgical treatment for endometriosis: the predictive value of the current classification system","volume":"21","author":"Vercellini","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2741\/E648","article-title":"Recurrence of endometrioma after laparoscopic excision and its prevention by medical management","volume":"5","author":"Koga","year":"2013","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/humupd\/dmp007","article-title":"Recurrence of endometriosis and its control","volume":"15","author":"Guo","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.rbmo.2010.04.018","article-title":"Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence","volume":"21","author":"Vercellini","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib12","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1093\/humrep\/des274","article-title":"In women with endometriosis anti-M\u00fcllerian hormone levels are decreased only in those with previous endometrioma surgery","volume":"11","author":"Streuli","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib14","first-page":"81","article-title":"Dysmenorrhea and endometriosis in young women","volume":"56","author":"Harada","year":"2013","journal-title":"Yonago Acta Med"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0002-9378(81)90478-6","article-title":"Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness","volume":"139","author":"Biberoglu","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0002-9378(82)90433-1","article-title":"An epidemiologic study of young women with dysmenorrhea","volume":"144","author":"Andersch","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/09513590.2011.634936","article-title":"A new oral contraceptive regimen for endometriosis management: prelim experience with 24\/4-day drospirenone\/ethinilestradiol 3mg\/20mcg","volume":"28","author":"Mabrouk","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib18","first-page":"989","article-title":"Does presence of coexisting disease modulate the effectiveness of a low-dose estrogen\/progestin, ethinylestradiol\/drospirenone combination tablet in dysmenorrhea? Reanalysis of two randomized studies in Japanese women","volume":"6","author":"Momoeda","year":"2014","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.fertnstert.2009.03.083","article-title":"Long-term oral contraceptive pills and postoperatrive pain management after laparoscopic excision of ovarian endometroma: a randomized controlled trial","volume":"94","author":"Seracchioli","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.fertnstert.2007.09.060","article-title":"A gonadotropin-releasing hormone agonist versus a continuous oral contraceptive pill in the treatment of bladder endometriosis","volume":"90","author":"Fedele","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.08.051_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1600-0412.2012.01366.x","article-title":"Continuous low-dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonography","volume":"91","author":"Ferrari","year":"2012","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216627905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:36:28Z","timestamp":1768221388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216627905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0015028216627905"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.051","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726825221.793535716","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a\u00a0placebo-controlled, double-blind, randomized trial","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}